CD276 and cancer: Recently, soluble forms of immune checkpoint molecules including PD-1, PD-L1, B7-H3, and B7-H4 in cancer have been demonstrated to be correlated with advanced stage, metastatic status, prognosis, and ICI treatment of patients with cancer [15, 16].